These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21135032)

  • 1. Successful differentiation to T cells, but unsuccessful B-cell generation, from B-cell-derived induced pluripotent stem cells.
    Wada H; Kojo S; Kusama C; Okamoto N; Sato Y; Ishizuka B; Seino K
    Int Immunol; 2011 Jan; 23(1):65-74. PubMed ID: 21135032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
    Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
    Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of electrophysiologically functional cardiomyocytes from mouse induced pluripotent stem cells.
    Wang H; Xi Y; Zheng Y; Wang X; Cooney AJ
    Stem Cell Res; 2016 Mar; 16(2):522-30. PubMed ID: 26972055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of murine embryonic stem and induced pluripotent stem cells to renal lineage in vitro.
    Morizane R; Monkawa T; Itoh H
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1334-9. PubMed ID: 19883625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
    Zhou W; Freed CR
    Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T lineage differentiation from induced pluripotent stem cells.
    Lei F; Haque R; Weiler L; Vrana KE; Song J
    Cell Immunol; 2009; 260(1):1-5. PubMed ID: 19811778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
    Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
    Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of germline-competent induced pluripotent stem cells.
    Okita K; Ichisaka T; Yamanaka S
    Nature; 2007 Jul; 448(7151):313-7. PubMed ID: 17554338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming to iPS cells and their subsequent hematopoietic differentiation is more efficient from MEFs than from preB cells.
    Reimer A; Seiler K; Tornack J; Tsuneto M; Melchers F
    Immunol Lett; 2012 Mar; 143(1):70-6. PubMed ID: 22313949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
    Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
    Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of reprogrammed mouse cardiac fibroblasts into functional cardiomyocytes.
    Jiang B; Dong H; Li Q; Yu Y; Zhang Z; Zhang Y; Wang G; Zhang Z
    Cell Biochem Biophys; 2013 Jun; 66(2):309-18. PubMed ID: 23212180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of induced pluripotent stem cells from aged mice using bone marrow-derived myeloid cells.
    Cheng Z; Ito S; Nishio N; Xiao H; Zhang R; Suzuki H; Okawa Y; Murohara T; Isobe K
    J Mol Cell Biol; 2011 Apr; 3(2):91-8. PubMed ID: 21228011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cells expressing elevated levels of sox-2, oct-4, and klf-4 are severely reduced in their differentiation from mesodermal to hematopoietic progenitor cells.
    Seiler K; Soroush Noghabi M; Karjalainen K; Hummel M; Melchers F; Tsuneto M
    Stem Cells Dev; 2011 Jul; 20(7):1131-42. PubMed ID: 21348597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced immunogenicity of induced pluripotent stem cells derived from Sertoli cells.
    Wang X; Qin J; Zhao RC; Zenke M
    PLoS One; 2014; 9(8):e106110. PubMed ID: 25166861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse-induced pluripotent stem cells generated under hypoxic conditions in the absence of viral infection and oncogenic factors and used for ischemic stroke therapy.
    Liu SP; Fu RH; Wu DC; Hsu CY; Chang CH; Lee W; Lee YD; Liu CH; Chien YJ; Lin SZ; Shyu WC
    Stem Cells Dev; 2014 Feb; 23(4):421-33. PubMed ID: 24266622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient Notch signaling induces NK cell potential in Pax5-deficient pro-B cells.
    Carotta S; Brady J; Wu L; Nutt SL
    Eur J Immunol; 2006 Dec; 36(12):3294-304. PubMed ID: 17111353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. iPS cells: a source of cardiac regeneration.
    Yoshida Y; Yamanaka S
    J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
    J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines.
    Féraud O; Valogne Y; Melkus MW; Zhang Y; Oudrhiri N; Haddad R; Daury A; Rocher C; Larbi A; Duquesnoy P; Divers D; Gobbo E; Brunet de la Grange P; Louache F; Bennaceur-Griscelli A; Mitjavila-Garcia MT
    PLoS One; 2016; 11(3):e0149291. PubMed ID: 26938212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction and characterization of induced pluripotent stem (iPS) cells: a review].
    Cheng D; Lei L; Lu Z; Li Z; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):421-30. PubMed ID: 20575428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.